139 related articles for article (PubMed ID: 18307986)
1. Synergistic effects of the polymorphisms in the PAI-1 and IL-6 genes with smoking in determining their associated risk with coronary artery disease.
Sarecka B; Zak I; Krauze J
Clin Biochem; 2008 May; 41(7-8):467-73. PubMed ID: 18307986
[TBL] [Abstract][Full Text] [Related]
2. Cigarette smoking, carrier state of A or G allele of 46A>G and 79C>G polymorphisms of beta2-adrenergic receptor gene, and the risk of coronary artery disease.
Zak I; Sarecka-Hujar B; Krauze J
Kardiol Pol; 2008 Apr; 66(4):380-6; discussion 387. PubMed ID: 18473266
[TBL] [Abstract][Full Text] [Related]
3. Contemporaneous carrier-state of two or three "proatherosclerotic" variants of APOE, ICAM1, PPARA and PAI-1 genes differentiate CAD patients from healthy individuals.
Zak I; Balcerzyk A; Sarecka B; Niemiec P; Ciemniewski Z; Dylag S
Clin Chim Acta; 2005 Dec; 362(1-2):110-8. PubMed ID: 16043164
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effects between Q192R polymorphism of paraoxonase 1 gene and some conventional risk factors in premature coronary artery disease.
Balcerzyk A; Zak I; Krauze J
Arch Med Res; 2007 Jul; 38(5):545-50. PubMed ID: 17560461
[TBL] [Abstract][Full Text] [Related]
5. Impact of plasminogen activator inhibitor-1 gene polymorphisms on primary membranous nephropathy.
Chen CH; Shu KH; Wen MC; Chen KJ; Cheng CH; Lian JD; Wu MJ; Yu TM; Tsai FJ
Nephrol Dial Transplant; 2008 Oct; 23(10):3166-73. PubMed ID: 18495745
[TBL] [Abstract][Full Text] [Related]
6. [Association of PAI-1 gene polymorphism with prognosis of coronary artery disease].
Zhang AY; Ji XW; Guan LX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):233-5. PubMed ID: 18393255
[TBL] [Abstract][Full Text] [Related]
7. Carrier-state of two or three polymorphic variants of MTHFR, IL-6 and ICAM1 genes increases the risk of coronary artery disease.
Sarecka-Hujar B; Zak I; Krauze J
Kardiol Pol; 2008 Dec; 66(12):1269-77. PubMed ID: 19169973
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between polymorphisms of plasminogen activator inhibitor-1 promoter gene and pulmonary thromboembolism in Chinese Han population].
Zhai ZG; Wang C; Yang YH; Pang BS; Xiao B; Liu YM; Mao YL; Weng XZ
Zhonghua Yi Xue Za Zhi; 2006 May; 86(19):1313-7. PubMed ID: 16796899
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-1 polymorphism (4G/5G) predicts recurrence in nonhyperlipidemic postinfarction patients.
Corsetti JP; Ryan D; Moss AJ; Rainwater DL; Zareba W; Sparks CE
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):548-54. PubMed ID: 18096824
[TBL] [Abstract][Full Text] [Related]
10. Platelet polymorphisms: frequency distribution and association with coronary artery disease in an Indian population.
Ashavaid TF; Todur SP; Kondkar AA; Nair KG; Shalia KK; Dalal JJ; Rajani R; Ponde CK
Platelets; 2011; 22(2):85-91. PubMed ID: 21034162
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 gene cluster polymorphisms and risk of coronary artery disease.
Vohnout B; Di Castelnuovo A; Trotta R; D'Orazi A; Panniteri G; Montali A; Donati MB; Arca M; Iacoviello L
Haematologica; 2003 Jan; 88(1):54-60. PubMed ID: 12551827
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis: Edinburgh Artery Study.
Lee AJ; Fowkes FG; Lowe GD; Connor JM; Rumley A
Thromb Haemost; 1999 Apr; 81(4):553-60. PubMed ID: 10235438
[TBL] [Abstract][Full Text] [Related]
13. The risk of coronary artery disease associated with cigarette smoking and hypercholesterolemia is additionally increased by the presence of the AT1R gene 1166C allele.
Niemiec P; Zak I; Wita K
Biochem Genet; 2008 Dec; 46(11-12):799-809. PubMed ID: 18787943
[TBL] [Abstract][Full Text] [Related]
14. No association of interleukin-6 gene polymorphism (-174 G/C) with premature coronary artery disease in a Turkish cohort.
Sekuri C; Cam FS; Sagcan A; Ercan E; Tengiz I; Alioglu E; Berdeli A
Coron Artery Dis; 2007 Aug; 18(5):333-7. PubMed ID: 17627181
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression.
Ramón LA; Gilabert-Estellés J; Cosín R; Gilabert J; España F; Castelló R; Chirivella M; Romeu A; Estellés A
Thromb Res; 2008; 122(6):854-60. PubMed ID: 18423526
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of cytochrome P450 1A1, cigarette smoking and risk of coronary artery disease.
Yeh CC; Sung FC; Kuo LT; Hsu WP; Chu HY
Mutat Res; 2009 Jul; 667(1-2):77-81. PubMed ID: 19563927
[TBL] [Abstract][Full Text] [Related]
17. Gene-gene interaction affects coronary artery disease risk.
Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrao M; Ornelas I; Freitas S; Freitas C; Araújo JJ; Brehm A; Cardoso AA
Rev Port Cardiol; 2009 Apr; 28(4):397-415. PubMed ID: 19634497
[TBL] [Abstract][Full Text] [Related]
18. [The application of DNA sequencing in studying haplotypes of PAI-1 gene in patients with coronary artery disease].
Wang XD; Fu Y; Jian HJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):400-2. PubMed ID: 15300646
[TBL] [Abstract][Full Text] [Related]
19. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients.
Ezzidi I; Mtiraoui N; Chaieb M; Kacem M; Mahjoub T; Almawi WY
Diabetes Metab; 2009 Jun; 35(3):214-9. PubMed ID: 19419896
[TBL] [Abstract][Full Text] [Related]
20. Is LOX-1 K167N polymorphism protective for coronary artery disease?
Kurnaz O; Aydogan HY; Isbir CS; Tekeli A; Isbir T
In Vivo; 2009; 23(6):969-73. PubMed ID: 20023241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
